Eurofins DiscoverX

Eurofins DiscoverX, the products company of Eurofins Discovery, is committed to enabling and accelerating multi-modality drug discovery and development from discovery to QC lot release. For drug discovery and development scientists, Eurofins DiscoverX is the trusted product solutions provider that accelerates research and drug discovery programs with confidence for cytokine receptors, checkpoint receptors, GPCRs, kinases, ion channels, epigenetics, nuclear receptors, and other target families. Eurofins DiscoverX develops and manufactures cutting edge assays, stable cell lines, ready-to-use kits (including bioassays), membrane preps, enzymes, and reagents for small molecule and biologic immuno-oncology, cytotoxicity, compound-target engagement, potency and QC lot release, pharmacotrafficking, and...

Drug discovery,gpcr,kinase,epigenetics,immuno-oncology,phenotypic profiling,cell-based assays,drug discovery products,bioassays,cyotoxicity,cytokine receptors,compound target engagement,custom assay development,and kinases

Eurofins discoverx operates in the Biotechnology research industry.

Eurofins discoverx's revenue is 11m - 100m

Eurofins discoverx has 51 - 200 employees.